293 related articles for article (PubMed ID: 16008621)
1. Pan-drug-resistant Pseudomonas aeruginosa causing nosocomial infection at a university hospital in Taiwan.
Hsueh PR; Tseng SP; Teng LJ; Ho SW
Clin Microbiol Infect; 2005 Aug; 11(8):670-3. PubMed ID: 16008621
[TBL] [Abstract][Full Text] [Related]
2. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey.
Yetkin G; Otlu B; Cicek A; Kuzucu C; Durmaz R
Am J Infect Control; 2006 May; 34(4):188-92. PubMed ID: 16679175
[TBL] [Abstract][Full Text] [Related]
3. Genetic fingerprinting and antimicrobial susceptibility profiles of Pseudomonas aeruginosa hospital isolates in Malaysia.
Lim KT; Yasin RM; Yeo CC; Puthucheary SD; Balan G; Maning N; Wahab ZA; Ismail N; Tan EA; Mustaffa A; Thong KL
J Microbiol Immunol Infect; 2009 Jun; 42(3):197-209. PubMed ID: 19812853
[TBL] [Abstract][Full Text] [Related]
4. Investigation of a nosocomial outbreak by alginate-producing pan-antibiotic-resistant Pseudomonas aeruginosa.
Yakupogullari Y; Otlu B; Dogukan M; Gursoy C; Korkmaz E; Kizirgil A; Ozden M; Durmaz R
Am J Infect Control; 2008 Dec; 36(10):e13-8. PubMed ID: 19084158
[TBL] [Abstract][Full Text] [Related]
5. Analysis of resistance, cross-resistance and antimicrobial combinations for Pseudomonas aeruginosa isolates from 1997 to 2009.
Master RN; Clark RB; Karlowsky JA; Ramirez J; Bordon JM
Int J Antimicrob Agents; 2011 Oct; 38(4):291-5. PubMed ID: 21737249
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial therapy and control of multidrug-resistant Pseudomonas aeruginosa bacteremia in a teaching hospital in Taiwan.
Leung CH; Wang NY; Liu CP; Weng LC; Hsieh FC; Lee CM
J Microbiol Immunol Infect; 2008 Dec; 41(6):491-8. PubMed ID: 19255693
[TBL] [Abstract][Full Text] [Related]
7. Pandrug-resistant Pseudomonas aeruginosa among hospitalised patients: clinical features, risk-factors and outcomes.
Wang CY; Jerng JS; Chen KY; Lee LN; Yu CJ; Hsueh PR; Yang PC
Clin Microbiol Infect; 2006 Jan; 12(1):63-8. PubMed ID: 16460548
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic susceptibility patterns of Pseudomonas aeruginosa to available antipseudomonal drugs in Ibadan, Nigeria.
Ogbolu DO; Ogunledun A; Adebiyi OE; Daini OA; Alli AO
Afr J Med Med Sci; 2008 Dec; 37(4):339-44. PubMed ID: 19301711
[TBL] [Abstract][Full Text] [Related]
9. Outbreak of carbapenem-resistant Pseudomonas aeruginosa infection in a surgical intensive care unit.
Kohlenberg A; Weitzel-Kage D; van der Linden P; Sohr D; Vögeler S; Kola A; Halle E; Rüden H; Weist K
J Hosp Infect; 2010 Apr; 74(4):350-7. PubMed ID: 20170982
[TBL] [Abstract][Full Text] [Related]
10. Nosocomial spread of class 1 integron-carrying extensively drug-resistant Pseudomonas aeruginosa isolates in a Thai hospital.
Kiddee A; Henghiranyawong K; Yimsabai J; Tiloklurs M; Niumsup PR
Int J Antimicrob Agents; 2013 Oct; 42(4):301-6. PubMed ID: 23845503
[TBL] [Abstract][Full Text] [Related]
11. Risk factors and clinical outcomes of nosocomial multi-drug resistant Pseudomonas aeruginosa infections.
Cao B; Wang H; Sun H; Zhu Y; Chen M
J Hosp Infect; 2004 Jun; 57(2):112-8. PubMed ID: 15183240
[TBL] [Abstract][Full Text] [Related]
12. [Evolution of antimicrobial resistance against Pseudomonas aeruginosa in a French university hospital between 2002 and 2006].
Minchella A; Molinari L; Alonso S; Bouziges N; Sotto A; Lavigne JP
Pathol Biol (Paris); 2010 Feb; 58(1):1-6. PubMed ID: 19875241
[TBL] [Abstract][Full Text] [Related]
13. Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa carrying metallo-beta-lactamase genes in Taiwan.
Huang YT; Chang SC; Lauderdale TL; Yang AJ; Wang JT
Diagn Microbiol Infect Dis; 2007 Oct; 59(2):211-6. PubMed ID: 17521840
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial resistance among clinical isolates of Pseudomonas aeruginosa from patients in a teaching hospital, Riyadh, Saudi Arabia, 2001-2005.
Babay HA
Jpn J Infect Dis; 2007 May; 60(2-3):123-5. PubMed ID: 17515646
[TBL] [Abstract][Full Text] [Related]
15. Evolution of the antimicrobial resistance of Pseudomonas aeruginosa in Spain: second national study (2003).
Sánchez-Romero I; Cercenado E; Cuevas O; García-Escribano N; García-Martínez J; Bouza E;
Rev Esp Quimioter; 2007 Jun; 20(2):222-9. PubMed ID: 17893760
[TBL] [Abstract][Full Text] [Related]
16. Molecular epidemiology of multidrug-resistant Pseudomonas aeruginosa in a French university hospital.
Cholley P; Gbaguidi-Haore H; Bertrand X; Thouverez M; Plésiat P; Hocquet D; Talon D
J Hosp Infect; 2010 Dec; 76(4):316-9. PubMed ID: 20692070
[TBL] [Abstract][Full Text] [Related]
17. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-{beta}-lactamase in a teaching hospital in southern Brazil.
Zavascki AP; Gaspareto PB; Martins AF; Gonçalves AL; Barth AL
J Antimicrob Chemother; 2005 Dec; 56(6):1148-51. PubMed ID: 16239284
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility of Pseudomonas aeruginosa isolates obtained from patients in Canadian intensive care units as part of the Canadian National Intensive Care Unit study.
Walkty A; Decorby M; Nichol K; Mulvey MR; Hoban D; Zhanel G;
Diagn Microbiol Infect Dis; 2008 Jun; 61(2):217-21. PubMed ID: 18304774
[TBL] [Abstract][Full Text] [Related]
19. The role of interventional molecular epidemiology in controlling clonal clusters of multidrug resistant Pseudomonas aeruginosa in critically ill cancer patients.
Adachi JA; Perego C; Graviss L; Dvorak T; Hachem R; Chemaly RF; Raad II
Am J Infect Control; 2009 Aug; 37(6):442-6. PubMed ID: 19118923
[TBL] [Abstract][Full Text] [Related]
20. [Susceptibility patterns of Pseudomonas aeruginosa strains isolated in the Monastir region, Tunisia].
Abdallah HB; Noomen S; Khélifa AB; Sahnoun O; Elargoubi A; Mastouri M
Med Mal Infect; 2008 Oct; 38(10):554-6. PubMed ID: 18814981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
